IIPLA News
Thursday, May 14, 2026

Federal Court Dismisses Factor2 Multimedia’s Challenge to PTO’s Ex Parte Patent Reexaminations

Claims that ex parte reexaminations violate constitutional rights rejected; motions to stay and amend complaint also denied

IIPLA News Deskanonymous access0 articles left this week
Federal Court Dismisses Factor2 Multimedia’s Challenge to PTO’s Ex Parte Patent Reexaminations
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

A federal court has dismissed Factor2 Multimedia Systems LLC’s lawsuit alleging that the U.S. Patent and Trademark Office’s (PTO) ex parte reexamination proceedings violate the Seventh and Fifth Amendments. The court held that patent rights are public rights subject to administrative adjudication and that no jury tria…
Share This Article
Ready-to-post copy includes the article link.

Federal Court Dismisses Factor2 Multimedia’s Challenge to PTO’s Ex Parte Patent Reexaminations A federal court has dismissed Factor2 Multimedia Systems LLC’s lawsuit alleging that the U.S. Patent and Trademark Office’s (PTO) ex parte reexamination proceedings violate the Seventh and Fifth Amendments. The court he... Read the full IIPLA article: https://iipla.org/news/federal-court-dismisses-factor2-multimedia-s-challenge-to-pto-s-ex-parte-patent-reexaminations

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsEurope

EUIPO Launches €27 Million Fund to Strengthen IP Protection for European SMEs in 2023

In 2023, the EUIPO has introduced a €27 million SME Fund aimed at enhancing intellectual property protection for European small and medium-sized enterprises (SMEs). This initiative is designed to facilitate SMEs’ access to IP rights, helping them safeguard innovations and boost competitiveness in the EU market.

Thursday, May 14, 2026
LitigationUSA

Supreme Court Declines to Review Purdue Pharma’s OxyContin Patent Dispute

The U.S. Supreme Court has opted not to take up Purdue Pharma’s appeal concerning patent litigation over its opioid medication OxyContin. This decision means that prior rulings against Purdue in the patent dispute remain in effect, potentially impacting the company’s control over the drug’s intellectual property right…

Thursday, May 14, 2026
PatentsSoutheast Asia

WIPO Provides Comprehensive Intellectual Property Data on Singapore

The World Intellectual Property Organization (WIPO) has compiled extensive intellectual property data for Singapore, highlighting the country's patent activity and IP environment. This resource serves as a key reference for understanding Singapore's position in the global IP framework.

Thursday, May 14, 2026